Research on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC Therapy
Clinical trial NCT07689929 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07689929
- Sponsor
- Zhejiang Cancer Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-08-01
- Primary completion
- 2028-06-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.